跳至主要内容
临床试验/ACTRN12617000211369
ACTRN12617000211369已完成4 期

Quality of Life (QoL) in schizophrenia patients on Abilify Maintena (Aripiprazole) versus treatment with other atypical anti-psychotics (oral or depot) in a private mental health setting: a pilot randomized controlled trial.

Dr. Benjamin Hadikusumo0 个研究点目标入组 36 人开始时间: 2017年2月8日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
36

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • Patients with a formal diagnosis of Schizophrenia as per DSM-V, patients aged between 18 and 65 (inclusive), able to give informed consent.

排除标准

  • Patients who are currently receiving Clozapine, patients with other serious comorbid psychiatric or medical illness, patients who are treatment refractory, patients who are pregnant or breastfeeding, patients who have concomitant use of any other antipsychotic

研究者

发起方
Dr. Benjamin Hadikusumo

相似试验